Screening 2000 biomarkers with qPCR assays at once
NGS performance at PCR costs
OUR MISSION
We aim to transform in vitro diagnostics by conducting hundreds of thousands of biochemical reactions simultaneously, giving doctors a comprehensive understanding of each patient's situation.
At VibrantBio, we believe that everyone deserves access to accurate and reliable molecular diagnosis. That's why we've created a technology that allows for faster, more comprehensive, and more precise testing that everyone can afford.
OUR SERVICES
We provide products tailored for a wide range of applications
Oncology
Our unique technology enables the detection of hundreds of cancer-related biomarkers in 2 hours, helping oncologists prescribe personalized medicine to more patients.
Infectious Diseases
Diagnosing the cause of infection is the key to prompt treatments. VibrantBio develops molecular tests that comprehensively screen possible pathogens within 2 hours.
Pathogen Screening
A smart surveillance strategy involves targeted monitoring of wildlife, domestic animals, and high-risk human interfaces in disease hotspots.
VibrantBio is developing a massively multiplexed qPCR-based technique capable of detecting 100-1,000 pathogens simultaneously. This innovation promises a swift turnaround, akin to regular qPCR, and lower associated costs, addressing the existing limitations in pathogen surveillance.
Biomedical Research
Nucleic acid identification and quantification is a fundamental methodology in bioscience.
VibrantBio is developing a massively multiplexed qPCR technique that allows genome-wide qPCR assays with low cost and quick turnaround times similar to regular qPCR assays.
VibrantBio in Numbers
2000
Biomarkers
3
Publications
2 h
Run time
8
Patents